Adaptive Biotechnologies Corp (ADPT) › Shareholders' EquityAdaptive Biotechnologies Corp (ADPT) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2016: -$189.73M2017: -$224.62M2018: -$258.11M2019: $571.04M2020: $743.27M2021: $603.99M2022: $464.17M2023: $308.40M2024: $202.71M2025: $218.79M$218.79M2016Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$218.79M+7.9%2024$202.71M-34.3%2023$308.40M-33.6%2022$464.17M-23.2%2021$603.99M-18.7%2020$743.27M+30.2%2019$571.04M+321.2%2018-$258.11M-14.9%2017-$224.62M-18.4%2016-$189.73M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share